SCHEMBL20805845

SCHEMBL20805845

O=C(Nc1ccc(Oc2ccc(C(=O)NCCO)cc2)cc1)Nc1ccc(OC(F)(F)F)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 8/20 0.67
▸ FAAH O00519 4/20 0.67
▸ MCHR1 Q99705 2/20 0.67
▸ MMP13 P45452 1/20 0.56
▸ TRPV1 Q8NER1 6/20 0.55
▸ NAMPT P43490 1/20 0.55
▸ HDAC3 O15379 1/20 0.53
▸ HDAC4 P56524 1/20 0.53
▸ HDAC1 Q13547 1/20 0.53
▸ HDAC7 Q8WUI4 1/20 0.53
▸ HDAC2 Q92769 1/20 0.53
▸ HDAC10 Q969S8 1/20 0.53
▸ HDAC11 Q96DB2 1/20 0.53
▸ HDAC8 Q9BY41 1/20 0.53
▸ HDAC6 Q9UBN7 1/20 0.53
▸ HDAC9 Q9UKV0 1/20 0.53
▸ HDAC5 Q9UQL6 1/20 0.53
▸ RAF1 P04049 1/20 0.51
▸ ABL1 P00519 1/20 0.49
▸ BCR P11274 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19835594 0.87 TRPV1 (0.64) EPHX2FAAHMCHR1MMP13TRPV1
SCHEMBL20805896 0.85 EPHX2 (0.70) EPHX2FAAHMCHR1TRPV1NAMPT
SCHEMBL20805895 0.84 EPHX2 (0.67) EPHX2FAAHMCHR1TRPV1NAMPT
SCHEMBL20805899 0.82 MAPK14 (0.70) EPHX2FAAHMCHR1MMP13NAMPT
SCHEMBL20805897 0.82 EPHX2 (0.73) EPHX2FAAHMCHR1MMP13TRPV1
SCHEMBL6152168 0.81 EPHX2 (0.68) EPHX2FAAHMCHR1NAMPTRAF1
SCHEMBL4258215 0.80 EPHX2 (1.00) EPHX2FAAHTRPV1HDAC3HDAC4
SCHEMBL19358927 0.80 EPHX2 (1.00) EPHX2FAAHRAF1
SCHEMBL19358926 0.80 EPHX2 (1.00) EPHX2FAAHRAF1
SCHEMBL6107273 0.80 MCHR1 (1.00) EPHX2MCHR1HDAC3HDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10858338-B2 Inhibitors for soluble epoxide hydrolase (SEH) and fatty acid amide hydrolase (FAAH) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2020-12-08 — — US disclosed
US-20190077785-A1 INHIBITORS FOR SOLUBLE EPOXIDE HYDROLASE (SEH) AND FATTY ACID AMIDE HYDROLASE (FAAH) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2019-03-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10858338-B2 Inhibitors for soluble epoxide hydrolase (SEH) and fatty acid amide hydrolase (FAAH) FAAH, FAAH2, EPHX2 EPHX2 3/4885FAAH 1/4885MCHR1 4118/4885
US-20190077785-A1 INHIBITORS FOR SOLUBLE EPOXIDE HYDROLASE (SEH) AND FATTY ACID AMIDE HYDROLASE (FAAH) FAAH, FAAH2, EPHX2 EPHX2 3/4885FAAH 1/4885MCHR1 4118/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback